Top Needle-free Drug Delivery Devices Companies

The global needle-free drug delivery devices market is defined by its competitive environment. This landscape includes all market players striving to gain the largest market share. This intense competition has driven the market’s growth. Some industry leaders include 3M, Pfizer, Johnson & Johnson, and Medtronic. These companies dominate the market. They have achieved this by using their best advantages. They include tremendous R&D efforts and a wide range of products.

The market is open to other contenders, driving further competition. Up-and-coming participants, such as Zogenix and Portal Instruments, are also making their mark on the market. They are able to do so with the introduction and use of innovative technologies. In order to spread their global presence and introduce more products into the market, players employ several tactics. One of these is the formation of alliances and collaborations to drive innovation. R&D investments are being made to create more patient-friendly and specialized drug delivery systems.

The compliance with rigid guidelines and safety requirements is crucial, That’s why regulatory standards and approvals heavily influence market growth. The competition in this market is heating up with continuous innovation and partnerships. Market players continue to secure a market share by meeting the needs for convenient and pain-free drug delivery techniques.

Top Player’s Company Profiles

• Becton, Dickinson and Company (BD) (USA)

• Zogenix (USA)

• Pfizer Inc. (USA)

• Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)

• Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)

• PharmaJet (USA)

• 3M (USA)

• National Medical Products Inc. (NMP Pharma) (USA)

• Antares Pharma (USA)

• Crossject (France)

• Novartis AG (Switzerland)

• Bioject Medical Technologies Inc. (USA)

• Pharmajet (USA)

• Astrazeneca (UK)

• Eli Lilly and Company (USA)

• MedImmune (USA, a subsidiary of AstraZeneca)

• Genentech (USA, a subsidiary of Roche)

• Inovio Pharmaceuticals (USA)

• Valeritas (USA)